http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113979913-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a3f59290f6caa361d490175d4661ead
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
filingDate 2021-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7835614fc46c3cc974396ae1da5d89f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af4757f561b09d3a057e4200234348c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7b211ba26a04aa807e7c7325c039bc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f75cffbb4a37d9976910656127a58aaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3611abf3b2305b108b2553f5400d9e10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c987cd93cd3a903e9a68b1091ad3ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec786b5dec810aa7633dcda743e0ef70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75ce7afc884062d8bccb9d8642292ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f03c0d6f0b729f4490d69e54a88c2ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1a4e847c4c0fe8cf63e61b906536403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_605bb91dc6c17c8c16602d58cf032769
publicationDate 2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113979913-A
titleOfInvention Method for synthesizing N,N-dimethyl-5-hydroxytryptamine-N12-oxide for treating viral drug
abstract The invention relates to the technical field of medicinal chemistry synthesis, and proposes a method for synthesizing a viral drug N,N-dimethyl-5-hydroxytryptamine-N 12 -oxide, comprising the following steps: S1, combining N,N -Dimethyl-5-hydroxytryptamine and phase transfer catalyst are added into ethanol and stirred to form a homogeneous solution; S2, dropwise add hydrogen peroxide ethanol solution, control dropwise temperature 0~5 ℃, continue to react after dropwise addition; S3, after deal with. Through the above technical solution, the problems of complex synthesis process, many chemical raw materials used, low yield and high cost in the prior art are solved.
priorityDate 2021-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102219725-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021230107-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448852283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450067302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408403335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID523077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452650124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449495704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410564352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453953771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453905787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87723553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44406820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140364308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451149986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454190246

Total number of triples: 62.